The FDA has extended the expiration date of some EpiPens due a shortage. Data from EpiPen maker Mylan was used to determine which devices could be extended. Some 0.3 milligram EpiPens have been given four more months of shelf life. (WebMD)
Lisa Suennen, senior MD at GE Ventures, is leaving the company, where her focus was health and technology investments. She has not elaborated on why she is departing or her future plans. (CNBC)
AbbVie is planning to invest $625 million more in a new immuno-oncology drug after investing $60 million two years ago in preclinical milestones. The treatment targets glycoprotein A repetitions predominant, or GARP. (Endpoints)
Facebook is launching a research project to improve MRI scans using artificial intelligence. The company is teaming up with New York University to improve the speed of MRIs, potentially making them up to 10 times faster. AI may be able to do this by capturing less data during the scan. (Business Insider)
The FDA has denied Allergan’s marketing application for its uterine fibroid drug. Esmya, a treatment for abnormal uterine bleeding in women, has caused liver damage in patients outside of the U.S., where the drug is available. (Endpoints)
